Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-029050
Filing Date
2025-02-27
Accepted
2025-02-27 16:13:14
Documents
87
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K crnx-20241231.htm   iXBRL 10-K 3677260
2 EX-10.19 crnx-ex10_19.htm EX-10.19 14371
3 EX-10.27 crnx-ex10_27.htm EX-10.27 207739
4 EX-23.1 crnx-ex23_1.htm EX-23.1 3358
5 EX-31.1 crnx-ex31_1.htm EX-31.1 19767
6 EX-31.2 crnx-ex31_2.htm EX-31.2 19724
7 EX-32.1 crnx-ex32_1.htm EX-32.1 6542
8 EX-32.2 crnx-ex32_2.htm EX-32.2 7076
9 GRAPHIC img65830419_0.jpg GRAPHIC 149106
10 GRAPHIC img65830419_1.jpg GRAPHIC 254065
  Complete submission text file 0000950170-25-029050.txt   15074445

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT crnx-20241231.xsd EX-101.SCH 1580268
90 EXTRACTED XBRL INSTANCE DOCUMENT crnx-20241231_htm.xml XML 2863062
Mailing Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121
Business Address 10222 BARNES CANYON ROAD, BLDG. #2 SAN DIEGO CA 92121 858-450-6464
Crinetics Pharmaceuticals, Inc. (Filer) CIK: 0001658247 (see all company filings)

EIN.: 263744114 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38583 | Film No.: 25678916
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)